Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Canadian Journal of Physiology and Pharmacology|January 1, 1996
The insulinotropic region of gastric inhibitory polypeptide; fragment analysis suggests the bioactive site lies between residues 19 and 30G W Morrow, T J Kieffer, C H McIntosh, et al.
Metabolism: Clinical and Experimental|March 27, 1999
Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidideR P Pauly, H U Demuth, F Rosche, et al.
Diabetes Care|October 27, 2001
Effect of glucagon-like peptide 1 on non-insulin-mediated glucose uptake in the elderly patient with diabetesG S Meneilly, C H McIntosh, R A Pederson, et al.
The Journal of Biological Chemistry|February 8, 2000
Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogsS A Hinke, J A Pospisilik, H U Demuth, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 29, 2001
Effect of aging and diabetes on the enteroinsular axisJ Korosi, C H McIntosh, R A Pederson, et al.
Regulatory Peptides|December 9, 2000
Metabolism of glucagon by dipeptidyl peptidase IV (CD26)J A Pospisilik, S A Hinke, R A Pederson, et al.
Pageof 9